Literature DB >> 11691637

Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus.

G Rondeau1, I Moreau, S Bézieau, J L Petit, R Heilig, S Fernandez, E Pennarun, J S Myers, M A Batzer, J P Moisan, M C Devilder.   

Abstract

In many haematological diseases, and more particularly in B-cell chronic lymphocytic leukaemia (B-CLL), the existence of a tumour suppressor gene located within the frequently deleted region 13q14.3, has been put forward. A wide candidate region spanning from marker D13S273 to D13S25 has been proposed and an extensive physical map has been constructed by several teams. In this study, we sequenced a minimal core deleted region that we have previously defined and annotated it with flanking available public sequences. Our analysis shows that this region is gene-poor. Furthermore, our work allowed us to identify new alternative transcripts, spanning core regions, of the previously defined candidate genes DLEU1 and DLEU2. Since their putative involvement in B-CLL was controversial, our present study provide support for reconsidering the DLEU1 and DLEU2 genes as B-CLL candidate genes, with a new definition of their organisation and context.

Entities:  

Mesh:

Year:  2001        PMID: 11691637     DOI: 10.1016/s0027-5107(01)00219-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  11 in total

Review 1.  Molecular basis of CLL.

Authors:  Yuri Pekarsky; Nicola Zanesi; Carlo M Croce
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

Review 2.  miR deregulation in CLL.

Authors:  Veronica Balatti; Yuri Pekarky; Lara Rizzotto; Carlo M Croce
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 3.  Genetics and molecular biology of chronic lymphocytic leukemia.

Authors:  Dennis A Carney; William G Wierda
Journal:  Curr Treat Options Oncol       Date:  2005-05

4.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

Review 5.  Noncoding RNA genes in cancer pathogenesis.

Authors:  Yuri Pekarsky; Carlo M Croce
Journal:  Adv Biol Regul       Date:  2018-12-13

6.  Seeking for senile-related gene expression in cerebral tissue of senescence-accelerated mouse.

Authors:  Chong Zhang; Jingang Wang; Jinyan Cheng; Guisheng Liu; Qingxuan Chen
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

7.  The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Roxane Collins; Sajid Shakhan; Jinghui Li; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Clin Cancer Res       Date:  2011-09-02       Impact factor: 12.531

Review 8.  Role of miR-15/16 in CLL.

Authors:  Y Pekarsky; C M Croce
Journal:  Cell Death Differ       Date:  2014-06-27       Impact factor: 15.828

Review 9.  BCL2 and miR-15/16: from gene discovery to treatment.

Authors:  Yuri Pekarsky; Veronica Balatti; Carlo M Croce
Journal:  Cell Death Differ       Date:  2017-10-06       Impact factor: 15.828

Review 10.  MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

Authors:  Katrien Van Roosbroeck; George A Calin
Journal:  Semin Oncol       Date:  2016-02-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.